Targeting SUMOylation Triggers IFN-β–Dependent Activation of Patient and Allogenic NK Cells in Preclinical Models of Acute Myeloid Leukemia

Researchers demonstrated that targeting SUMOylation, a protein posttranslational modification, activates NK cells from both healthy donors and patients with AML.